Chellgren Center Names 36 New Fellows, Five Endowed Professorships
NIH Public Access Policy Reference List
NIH Public Access Policy
Reference List
Overview:
Congratulations New AOA Inductee: Dustin Stevens
Congratulations to our new UK AOA inductees; including our very own Dustin Stevens!
Cancer treatment developed in Department of Surgery approved for clinical trials
LEXINGTON, Ky. (Aug. 28, 2015) – The Food and Drug Administration (FDA) approved clinical trials for an investigational cancer treatment pioneered by University of Kentucky researchers in the Department of Surgery.
The Exatherm Total Body Hyperthermia System (Exatherm-TBH) was developed at UK in a public-private partnership with Exatherm, LLC, explained medical researcher Cherry Ballard-Croft, Ph.D. The project received grant funding from the National Institutes of Health.
Croft.jpg
Markey, T.J. Samson Growing Oncology Program in Glasgow
T.J. Samson Community Hospital in Glasgow, Ky., announced that it has entered into a formal collaboration with the University of Kentucky Markey Cancer Center to further develop its oncology service line.
“At T.J. Samson we have wonderful medical professionals that are excellent at providing individualized treatment options. By collaborating with the Markey Cancer Center, we have just provided them a whole new world of resources to offer their patients locally,” Bud Wethington, CEO/President of T.J.
pavilion_-_main_entrance_low_shot.jpg
Postdoctoral position available: Dr. Nikolova-Karakashian Lab
A Postdoctoral position is available in the laboratory of Dr. Nikolova-Karakashian in the Department of Physiology at the UK College of Medicine. The person fulfilling this position will be involved in mentored research on the role of sphingolipids in hepatic inflammation, as it relates to aging and liver disease.
A recent Ph.D in any ares of cellular/molecular biology and 0 to 1 years of experience is required.
Francisco Andrade receives Chellgren Endowed Professorship
Daugherty lab publishes research on Fibroblast Angiotensin II Type 1A Receptors
Fibroblast Angiotensin II Type 1a Receptors Contribute to Angiotensin II–Induced Medial Hyperplasia in the Ascending Aorta
Aruna Poduri, Debra L. Rateri, Deborah A. Howatt, Anju Balakrishnan, Jessica J. Moorleghen,
Lisa A. Cassis, Alan Daugherty
Figure 4 from Daugherty lab ATVB article_1.png
Do you need to request a No Cost Extension for your grant?
Do you need to request a No Cost Extension for your grant? It’s extremely important you initiate this process prior to the end date of the project. The specific time frame depends on the sponsor, but at least 60 days in advance is recommended. Contact your GPS for assistance. You can find your assigned GPS here. The SRAS SOP for this process can be found here.
Four Grants in Six Months for Sanders-Brown Researcher
LEXINGTON, Ky. (Jun. 12, 2015) — A researcher from UK's Sanders-Brown Center on Aging has received four different grants in six months to explore both disease processes and potential treatments for Alzheimer's and related diseases.
_DSC5921JoeAbisambra.jpg
Why the HPV Vaccine Should be Addressed as Cancer Prevention
For women younger than 40, cervical cancer is among the leading causes of cancer-related death. With modern vaccines to protect against the underlying cause, human papilloma virus (HPV), cervical cancer is also one of the most preventable types of cancers.
As a society, we have the opportunity to wipe out or significantly reduce a disease by vaccinating the population.
omar_hatima_03_2.jpg